Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook ...
Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.
Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback